Perfluorocarbon-Based Red Blood Cell Substitutes

Transfusion Medicine Reviews

Volumn 7, Issue 2, 1993, Pages 84-95

  Biro, G P ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; FLUOROCARBON; FLUOSOL; OXYGEN;

BLEEDING; CARDIOVASCULAR SYSTEM; ERYTHROCYTE; IMAGING; ONCOLOGY; REVIEW; TISSUE OXYGENATION;

EID: 0027408414     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-7963(93)70127-3     Document Type: Article

References (50)

1. Blood substitutes based on modified hemoglobin and fluorochemicals
2. Chemically modified recombinant hemoglobin blood substitutes
3. Liposome-encapsulated hemoglobin: Historical development of a blood substitute
4. Perfluorocarbon blood substitutes
5. Preparation of perfluorochemicals emulsions for biomedical use: Principles, materials and methods
6. Fluorocarbon-based in vivo oxygen transport and delivery systems
7. Perfluorochemicals: Blood substitutes and beyond
8. Medical oxygen transport using perfluorochemicals
9. Fluorocarbon-based oxygen carriers: New orientations
10. Role of Fluosol-DA 20% in prehospital resuscitation
11. Blood substitutes and the cardiovascular system
12. Human studies involving perfluorochemical emulsions
13. Limitation of complement activation by perfluorocarbon emulsions. Superiority of lecithin-emulsified preparations
14. Fluorocarbons in the resuscitation of hemorrhage
15. 2 extraction following hemodilution with dextran or Fluosol-DA
16. New perfluorocarbon emulsion improves tissue oxygenation in cat retina
17. Role of fluid replacement, increased oxygen availability by perfluorochemicals and enhanced RES function in the treatment of mesenteric occlusion shock
18. Intestinal ischemia: Treatment by peritoneal lavage with oxygenated perfluorochemical
19. Prolonged support of working rabbit hearts using Fluosol-43 or erythrocyte media
20. Twenty-four-hour isolated heart preservation by perfusion method with oxygenated solution containing perfluorochemicals and albumin
21. Electron microscopic changes and edema after nine hours’ perfusion of isolated canine hearts
22. Oxygenated perfluorocarbon, recombinant human superoxide dismutase, and catalase ameliorate free radical induced myocardial injury during heart preservation and transplantation
23. Myocardial protection in the hypertrophied right ventricle
24. Prevention of neutrophil-mediated injury to endothelial cells by perfluorochemical
25. Protection against myocardial ischemia by prior haemodilution with fluorocarbon emulsions
26. Dose-dependent reduction of myocardial infarct size with the perfluorochemical Fluosol-DA
27. The effect of perfluorochemical Fluosol-DA (20%) on the myocardial infarct healing in the rabbit
28. Myocardial protection by perfluorochemical infusion during transient ischemia produced by balloon coronary occlusion
29. Inadequate subendocardial oxygen delivery during perfluorocarbon perfusion in a canine model of ischemia
30. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol-DA 20%
31. Perfluorochemical perfusion during coronary angioplasty in unstable and high-risk patients
32. Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty
33. Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol
34. Potential role of PFOB in diagnostic imaging
35. Perfluoroctylbromide and hepatosplenic computed tomography preliminary clinical study
36. Hemodynamic effeets of intravenous lecithin-based perfluorocarbon emulsions in dogs
37. Perfluorootyl bromide: acute hemodynamic effects in pigs, of intravenous administration compared with the standard ionic contrast media
38. The physiologic basis of the radiodense renal medulla after the administration of blood pool contrast agent PFOB
39. Perfluoroctylbromide: A new contrast agent for CT, sonography, and MR imaging
40. Perfluoroctylbromide as a gastrointestinal contrast agent for MR imaging: Use with and without glucagon
41. Attempts to increase intratumoral blood flow in the rat solid walker 256 tumor by the use of the perfluorocarbon emulsion Fluosol-DA
42. 2 and radiosensitivity of tumors by Fluosol-DA (20%) and carbogen
43. Fluosol and oxygen breathing as an adjuvant to radiation therapy in the treatment of locally advanced non-small cell carcinoma of the lung: Results of a phase I/II study
44. Modulation of tumor oxygenation and radiosensitivity by a perfluorooctylbromide emulsion
45. Effects of hyperbaric oxygen and a perfluorooctylbromide emulsion on the radiation responses of tumors and normal tissues in rodents
46. Perfluorocarbon liquid ventilation: The first human trial
47. Liquid ventilation of human preterm neonates
48. Cardiac output during liquid (perfluorocarbon) breathing in newborn piglets